Orthofix Medical Signs a License Agreement with LimaCorporate to Provide Novel Solution for High Hip Dislocation in the US
Shots:
- The companies collaborated to provide a novel solution for chronic high dislocation of the hip in the US & enables surgeons to divert the femur into a proper position thus resolving the leg-length disparity, reducing strain on the spine & enabling a total hip replacement
- The collaboration will combine the limb-lengthening technology of Orthofix’s patented Fitbone intramedullary nail system with LimaCorporate’s 3D-printed pelvic fixation device to provide technologies for hip dysplasia or abnormalities of the hip
- The US FDA compassionate use exemption will grant access to the new solution. LimaCorporate's ProMade 3D-printed custom service combines design & manufacture in its PoC Center located at HSS in New York City
Ref: Bussinesswire | Image: Orthofix
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
